218 related articles for article (PubMed ID: 715418)
1. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
2. [Purity and antigenicity of the new insulin preparations].
Fankhauser S
Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
[TBL] [Abstract][Full Text] [Related]
3. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
Bruni B; Gamba S; Regis G; Turco GL
Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
[TBL] [Abstract][Full Text] [Related]
4. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
5. Insulin antibodies in diabetics receiving a single type of insulin.
Mincu I; Cheţa D
Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
[TBL] [Abstract][Full Text] [Related]
6. Behaviour of insulin antibodies in diabetics treated with different insulins.
Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
[TBL] [Abstract][Full Text] [Related]
7. [Factors affecting the antigenicity of exogenous insulin in diabetics].
Penchev II; Taneva T; Ditsov S; Andreev D
Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with monocomponent insulins].
Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
[TBL] [Abstract][Full Text] [Related]
11. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
Saner B; Fankhauser S
Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
[TBL] [Abstract][Full Text] [Related]
12. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
Yue DK; Turtle JR
Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation].
Barbero L; Gamba S; Zanno C; Regis G; Bruni B
Minerva Med; 1978 Apr; 69(21):1437-42. PubMed ID: 683547
[TBL] [Abstract][Full Text] [Related]
14. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenicity of MC Lente Novo insulin].
Rogala H; Lawecki J; Czyzyk A
Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
[No Abstract] [Full Text] [Related]
16. The immunogenicity of insulin preparations.
Chance RE; Root MA; Galloway JA
Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of diabetic microangiopathy. Fluoroangioretinal observations during monocomponent insulin therapy].
Anselmetti G; Antoniotti V; Barbero PL; Castellazzi R; Gamba S; Bruni B
Ann Osp Maria Vittoria Torino; 1978; 21(1-6):47-68. PubMed ID: 756200
[TBL] [Abstract][Full Text] [Related]
18. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
19. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
[TBL] [Abstract][Full Text] [Related]
20. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day].
Cucinotta D; Lunetta M
Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
